NASA Astronauts Wilmore and Williams Recover After Boeing Starliner Delay 
U.S. Stock Futures Slide as Tech Rout Deepens on Amazon Capex Shock 
South Korea’s Weak Won Struggles as Retail Investors Pour Money Into U.S. Stocks 
Eli Lilly and Novo Nordisk Battle for India’s Fast-Growing Obesity Drug Market 
Japanese Pharmaceutical Stocks Slide as TrumpRx.gov Launch Sparks Market Concerns 
RFK Jr. Overhauls Federal Autism Panel, Sparking Medical Community Backlash 
Trump Backs Review of U.S. Childhood Vaccine Schedule After Hepatitis B Policy Change 
Jared Isaacman Confirmed as NASA Administrator, Becomes 15th Leader of U.S. Space Agency 
Merck Raises Growth Outlook, Targets $70 Billion Revenue From New Drugs by Mid-2030s 
SpaceX Starship Test Flight Reaches New Heights but Ends in Setback 
Royalty Pharma Stock Rises After Acquiring Full Evrysdi Royalty Rights from PTC Therapeutics 
Japan Economy Poised for Q4 2025 Growth as Investment and Consumption Hold Firm 
Sanofi Reports Positive Late-Stage Results for Amlitelimab in Eczema Treatment 
GLP-1 Weight Loss Pills Set to Reshape Food and Fast-Food Industry in 2025 
Dollar Steadies Ahead of ECB and BoE Decisions as Markets Turn Risk-Off 
Astronomers have discovered another puzzling interstellar object − this third one is big, bright and fast 
A new diagnostic method that ascertains if a person is suffering from Parkinson’s disease or dementia by looking at the manner of walking has been patented.
A new diagnostic technique developed by a St. Mary's Hospital research team in Uijeongbu has been patented and put up for patent registration, which analyses data from an individual's shoes to detect neurological disorders.
Most degenerative brain disorders, such as Parkinson's disease, dementia, and Lou Gehrig's disease, occur at an older age.
Currently, a costly MRI or a PET scan is required for such diagnosis, as well as frequent visits to the hospital.
The new approach, on the other hand, employs a "smart insole" that is placed inside a shoe and collects data from its sensors, which is then analyzed to assess the brain health of the wearer.
The new technique achieved an accuracy of 98.1 percent for the diagnosis of Parkinson's disease, as well as 83.2 percent for differentiating whether an illness is vascular or degenerative.
